CM-156

CM-156 is a nootropic compound developed by the Russian Academy of Sciences. It is a derivative of Phenylpiracetam, but with a higher potency and a broader range of effects.

History[edit | edit source]

CM-156 was developed by the Russian Academy of Sciences as part of their ongoing research into nootropic compounds. It is a derivative of Phenylpiracetam, a well-known nootropic that has been in use since the 1980s. The aim of the research was to develop a compound with a higher potency and a broader range of effects than Phenylpiracetam.

Pharmacology[edit | edit source]

CM-156 is a dopamine receptor agonist, meaning it stimulates the dopamine receptors in the brain. This can lead to increased focus, motivation, and mood. It also has antioxidant properties, which can protect the brain from damage caused by free radicals.

Clinical Trials[edit | edit source]

As of now, there have been limited clinical trials conducted on CM-156. However, preliminary studies suggest that it may have potential as a treatment for conditions such as Alzheimer's disease, Parkinson's disease, and stroke.

Side Effects[edit | edit source]

The side effects of CM-156 are not well-studied. However, as a derivative of Phenylpiracetam, it may share some of the same side effects, such as insomnia, irritability, and nausea.

See Also[edit | edit source]

CM-156 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.